Clinical Laboratory Service Comprehensive Study by Application (Hematology, Urinalysis, Microbiology, Immunochemistry, Others), Tests (Blood Testing, Urine Testing, Oral Fluid Testing, Hair Testing, Others), End User (Hospital Laboratory, Clinics, Private Laboratory, Others) Players and Region - Global Market Outlook to 2028

Clinical Laboratory Service Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 3.5%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Clinical Laboratory Service
Clinical laboratory service is to detect and monitor the test results done on specimens from the body like urine or blood of the patient and provide them with appropriate treatment. These tests are done in hospitals, clinics and various independent laboratories. Automation has been the greatest trend for change in the global clinical laboratory service market. Clinical Laboratory Improvement (CLIA) and the Center for Medicare and Medicaid Services (CMS) have set some regulations regarding the mandatory certification before collecting any human sample for diagnostic service. The market is affected by the COVID-19 testing service as the number of patients is increasing worldwide the need for the clinical laboratory services is increasing.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Billion)
CAGR3.5%


The competitive landscape of clinical laboratory services is characterized by a diverse array of providers offering diagnostic testing and analytical services to support healthcare professionals in patient care Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Clinical Laboratory Service market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott (Alere) (United States), Siemens Healthineers (Germany), Bio-Reference Laboratories Inc. (United States), Davita Labs (United States), Genomic Health, Inc (United States), SYN Lab International GmbH (Germany), Enzo Biochem Inc (United States), Quest Diagnostics (United States), Myriad Genetics (United States), Spectra Laboratories (United States), NeoGenomics Laboratories Inc (United States) and Labcorp (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Miraca Group (Japan), Sonic Healthcare (Australia) and Arup Laboratories (United States).

Segmentation Overview
AMA Research has segmented the market of Global Clinical Laboratory Service market by , Application (Hematology, Urinalysis, Microbiology, Immunochemistry and Others) and Region.



On the basis of geography, the market of Clinical Laboratory Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, Italy, France, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Tests, the sub-segment i.e. Blood Testing will boost the Clinical Laboratory Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital Laboratory will boost the Clinical Laboratory Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Adoption of Automation Technology Like Robots in Clinical Laboratory Service and Increasing Advancement in Testing Technologies

Market Growth Drivers:
Increasing Need for Testing and Clinical Care to Reduce both COVID-19 Transmission and Economic, Public Health, and Social Impacts and Rising Number of Patients Worldwide

Challenges:
Stringent Regulatory Norms Regarding Clinical Laboratory Service and Less Availability of Skilled Manpower in Laboratory might Hinder the Market Growth

Restraints:
Emerging Shortage of Resources in Clinical Laboratory Due to the Pandemic and Expenses Associated with Maintaining the Clinical Laboratory Service System

Opportunities:
Continuous Research and Development for Effective Medicines Discovery, Growing Health-Related Awareness in Developing Economies and Increasing Government Spendings on Clinical Laboratory Service

Market Leaders and their expansionary development strategies
In May 2023, Getlabs, the leading provider of at-home diagnostic collections, has partnered with Nice Healthcare, an in-home and virtual primary care clinic, to expand access to in-home healthcare services and lab testing. The partnership is expected to help improve access to these services, making it easier and more convenient for people to get the care they need.
In November 2023, Agilus Diagnostics on Wednesday announced the launch of a new laboratory in Bongaigaon, Assam. According to a press statement, the advanced laboratory has the capacity to process 25,000+ samples in a month ranging from simple routine tests to semi-specialized and specialized tests.
On Feb. 4, 2020, the Secretary of HHS determined that there is a public health emergency and that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of the COVID-19 outbreak. The FDA has authorized one EUA for COVID-19 that is in use by the U.S. Centers for Disease Control and Prevention (CDC) and some public health labs across the country. The guidance issued describes a policy enabling laboratories to immediately use tests they developed and validated in order to achieve more rapid testing capacity in the U.S. Following the completion of their test validation, laboratories should communicate with the FDA, via email, in order to notify the agency that the test has been validated. Laboratories should submit a completed EUA request within 15 business days of notification."

Key Target Audience
Clinical Laboratory Service Providers, Clinical Laboratory Machines Distributors and Suppliers, Research and Development Laboratory, Financial Institutes and Venture Capital, Hospitals, Regulatory Bodies and Others

Key Finding and Research Objectives
Understanding policy and regulatory proposal, designing clear explanations of the stakes, potential winners and losers, and options for improvement. Identifying Untapped Geographic Market Territory with growth Potential of Clinical Laboratory Service Market. Opportunities and Gap Analysis by Key Business Segments. To categorize the impact of regulation on long-term market growth.

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Hematology
  • Urinalysis
  • Microbiology
  • Immunochemistry
  • Others
By Tests
  • Blood Testing
  • Urine Testing
  • Oral Fluid Testing
  • Hair Testing
  • Others

By End User
  • Hospital Laboratory
  • Clinics
  • Private Laboratory
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • Italy
    • France
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Need for Testing and Clinical Care to Reduce both COVID-19 Transmission and Economic, Public Health, and Social Impacts
      • 3.2.2. Rising Number of Patients Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Norms Regarding Clinical Laboratory Service
      • 3.3.2. Less Availability of Skilled Manpower in Laboratory might Hinder the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Adoption of Automation Technology Like Robots in Clinical Laboratory Service
      • 3.4.2. Increasing Advancement in Testing Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Laboratory Service, by Application, Tests, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Clinical Laboratory Service (Value)
      • 5.2.1. Global Clinical Laboratory Service by: Application (Value)
        • 5.2.1.1. Hematology
        • 5.2.1.2. Urinalysis
        • 5.2.1.3. Microbiology
        • 5.2.1.4. Immunochemistry
        • 5.2.1.5. Others
      • 5.2.2. Global Clinical Laboratory Service by: Tests (Value)
        • 5.2.2.1. Blood Testing
        • 5.2.2.2. Urine Testing
        • 5.2.2.3. Oral Fluid Testing
        • 5.2.2.4. Hair Testing
        • 5.2.2.5. Others
      • 5.2.3. Global Clinical Laboratory Service by: End User (Value)
        • 5.2.3.1. Hospital Laboratory
        • 5.2.3.2. Clinics
        • 5.2.3.3. Private Laboratory
        • 5.2.3.4. Others
      • 5.2.4. Global Clinical Laboratory Service Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. Italy
          • 5.2.4.3.3. France
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Clinical Laboratory Service (Price)
  • 6. Clinical Laboratory Service: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott (Alere) (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Siemens Healthineers (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Reference Laboratories Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Davita Labs (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Genomic Health, Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. SYN Lab International GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Enzo Biochem Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Quest Diagnostics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Myriad Genetics (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Spectra Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. NeoGenomics Laboratories Inc (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Labcorp (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Clinical Laboratory Service Sale, by Application, Tests, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Clinical Laboratory Service (Value)
      • 7.2.1. Global Clinical Laboratory Service by: Application (Value)
        • 7.2.1.1. Hematology
        • 7.2.1.2. Urinalysis
        • 7.2.1.3. Microbiology
        • 7.2.1.4. Immunochemistry
        • 7.2.1.5. Others
      • 7.2.2. Global Clinical Laboratory Service by: Tests (Value)
        • 7.2.2.1. Blood Testing
        • 7.2.2.2. Urine Testing
        • 7.2.2.3. Oral Fluid Testing
        • 7.2.2.4. Hair Testing
        • 7.2.2.5. Others
      • 7.2.3. Global Clinical Laboratory Service by: End User (Value)
        • 7.2.3.1. Hospital Laboratory
        • 7.2.3.2. Clinics
        • 7.2.3.3. Private Laboratory
        • 7.2.3.4. Others
      • 7.2.4. Global Clinical Laboratory Service Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. Italy
          • 7.2.4.3.3. France
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Clinical Laboratory Service (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Laboratory Service: by Application(USD Billion)
  • Table 2. Clinical Laboratory Service Hematology , by Region USD Billion (2017-2022)
  • Table 3. Clinical Laboratory Service Urinalysis , by Region USD Billion (2017-2022)
  • Table 4. Clinical Laboratory Service Microbiology , by Region USD Billion (2017-2022)
  • Table 5. Clinical Laboratory Service Immunochemistry , by Region USD Billion (2017-2022)
  • Table 6. Clinical Laboratory Service Others , by Region USD Billion (2017-2022)
  • Table 7. Clinical Laboratory Service: by Tests(USD Billion)
  • Table 8. Clinical Laboratory Service Blood Testing , by Region USD Billion (2017-2022)
  • Table 9. Clinical Laboratory Service Urine Testing , by Region USD Billion (2017-2022)
  • Table 10. Clinical Laboratory Service Oral Fluid Testing , by Region USD Billion (2017-2022)
  • Table 11. Clinical Laboratory Service Hair Testing , by Region USD Billion (2017-2022)
  • Table 12. Clinical Laboratory Service Others , by Region USD Billion (2017-2022)
  • Table 13. Clinical Laboratory Service: by End User(USD Billion)
  • Table 14. Clinical Laboratory Service Hospital Laboratory , by Region USD Billion (2017-2022)
  • Table 15. Clinical Laboratory Service Clinics , by Region USD Billion (2017-2022)
  • Table 16. Clinical Laboratory Service Private Laboratory , by Region USD Billion (2017-2022)
  • Table 17. Clinical Laboratory Service Others , by Region USD Billion (2017-2022)
  • Table 18. South America Clinical Laboratory Service, by Country USD Billion (2017-2022)
  • Table 19. South America Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 20. South America Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 21. South America Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 22. Brazil Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 23. Brazil Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 24. Brazil Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 25. Argentina Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 26. Argentina Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 27. Argentina Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 28. Rest of South America Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 29. Rest of South America Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 30. Rest of South America Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 31. Asia Pacific Clinical Laboratory Service, by Country USD Billion (2017-2022)
  • Table 32. Asia Pacific Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 33. Asia Pacific Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 34. Asia Pacific Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 35. China Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 36. China Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 37. China Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 38. Japan Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 39. Japan Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 40. Japan Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 41. India Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 42. India Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 43. India Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 44. South Korea Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 45. South Korea Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 46. South Korea Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 47. Taiwan Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 48. Taiwan Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 49. Taiwan Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 50. Australia Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 51. Australia Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 52. Australia Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 53. Rest of Asia-Pacific Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 54. Rest of Asia-Pacific Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 55. Rest of Asia-Pacific Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 56. Europe Clinical Laboratory Service, by Country USD Billion (2017-2022)
  • Table 57. Europe Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 58. Europe Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 59. Europe Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 60. Germany Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 61. Germany Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 62. Germany Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 63. Italy Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 64. Italy Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 65. Italy Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 66. France Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 67. France Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 68. France Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 69. United Kingdom Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 70. United Kingdom Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 71. United Kingdom Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 72. Netherlands Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 73. Netherlands Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 74. Netherlands Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 75. Rest of Europe Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 76. Rest of Europe Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 77. Rest of Europe Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 78. MEA Clinical Laboratory Service, by Country USD Billion (2017-2022)
  • Table 79. MEA Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 80. MEA Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 81. MEA Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 82. Middle East Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 83. Middle East Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 84. Middle East Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 85. Africa Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 86. Africa Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 87. Africa Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 88. North America Clinical Laboratory Service, by Country USD Billion (2017-2022)
  • Table 89. North America Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 90. North America Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 91. North America Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 92. United States Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 93. United States Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 94. United States Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 95. Canada Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 96. Canada Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 97. Canada Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 98. Mexico Clinical Laboratory Service, by Application USD Billion (2017-2022)
  • Table 99. Mexico Clinical Laboratory Service, by Tests USD Billion (2017-2022)
  • Table 100. Mexico Clinical Laboratory Service, by End User USD Billion (2017-2022)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Clinical Laboratory Service: by Application(USD Billion)
  • Table 114. Clinical Laboratory Service Hematology , by Region USD Billion (2023-2028)
  • Table 115. Clinical Laboratory Service Urinalysis , by Region USD Billion (2023-2028)
  • Table 116. Clinical Laboratory Service Microbiology , by Region USD Billion (2023-2028)
  • Table 117. Clinical Laboratory Service Immunochemistry , by Region USD Billion (2023-2028)
  • Table 118. Clinical Laboratory Service Others , by Region USD Billion (2023-2028)
  • Table 119. Clinical Laboratory Service: by Tests(USD Billion)
  • Table 120. Clinical Laboratory Service Blood Testing , by Region USD Billion (2023-2028)
  • Table 121. Clinical Laboratory Service Urine Testing , by Region USD Billion (2023-2028)
  • Table 122. Clinical Laboratory Service Oral Fluid Testing , by Region USD Billion (2023-2028)
  • Table 123. Clinical Laboratory Service Hair Testing , by Region USD Billion (2023-2028)
  • Table 124. Clinical Laboratory Service Others , by Region USD Billion (2023-2028)
  • Table 125. Clinical Laboratory Service: by End User(USD Billion)
  • Table 126. Clinical Laboratory Service Hospital Laboratory , by Region USD Billion (2023-2028)
  • Table 127. Clinical Laboratory Service Clinics , by Region USD Billion (2023-2028)
  • Table 128. Clinical Laboratory Service Private Laboratory , by Region USD Billion (2023-2028)
  • Table 129. Clinical Laboratory Service Others , by Region USD Billion (2023-2028)
  • Table 130. South America Clinical Laboratory Service, by Country USD Billion (2023-2028)
  • Table 131. South America Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 132. South America Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 133. South America Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 134. Brazil Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 135. Brazil Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 136. Brazil Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 137. Argentina Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 138. Argentina Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 139. Argentina Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 140. Rest of South America Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 141. Rest of South America Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 142. Rest of South America Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 143. Asia Pacific Clinical Laboratory Service, by Country USD Billion (2023-2028)
  • Table 144. Asia Pacific Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 145. Asia Pacific Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 146. Asia Pacific Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 147. China Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 148. China Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 149. China Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 150. Japan Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 151. Japan Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 152. Japan Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 153. India Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 154. India Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 155. India Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 156. South Korea Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 157. South Korea Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 158. South Korea Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 159. Taiwan Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 160. Taiwan Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 161. Taiwan Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 162. Australia Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 163. Australia Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 164. Australia Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 165. Rest of Asia-Pacific Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 166. Rest of Asia-Pacific Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 167. Rest of Asia-Pacific Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 168. Europe Clinical Laboratory Service, by Country USD Billion (2023-2028)
  • Table 169. Europe Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 170. Europe Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 171. Europe Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 172. Germany Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 173. Germany Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 174. Germany Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 175. Italy Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 176. Italy Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 177. Italy Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 178. France Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 179. France Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 180. France Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 181. United Kingdom Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 182. United Kingdom Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 183. United Kingdom Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 184. Netherlands Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 185. Netherlands Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 186. Netherlands Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 187. Rest of Europe Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 188. Rest of Europe Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 189. Rest of Europe Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 190. MEA Clinical Laboratory Service, by Country USD Billion (2023-2028)
  • Table 191. MEA Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 192. MEA Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 193. MEA Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 194. Middle East Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 195. Middle East Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 196. Middle East Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 197. Africa Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 198. Africa Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 199. Africa Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 200. North America Clinical Laboratory Service, by Country USD Billion (2023-2028)
  • Table 201. North America Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 202. North America Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 203. North America Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 204. United States Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 205. United States Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 206. United States Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 207. Canada Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 208. Canada Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 209. Canada Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 210. Mexico Clinical Laboratory Service, by Application USD Billion (2023-2028)
  • Table 211. Mexico Clinical Laboratory Service, by Tests USD Billion (2023-2028)
  • Table 212. Mexico Clinical Laboratory Service, by End User USD Billion (2023-2028)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Laboratory Service: by Application USD Billion (2017-2022)
  • Figure 5. Global Clinical Laboratory Service: by Tests USD Billion (2017-2022)
  • Figure 6. Global Clinical Laboratory Service: by End User USD Billion (2017-2022)
  • Figure 7. South America Clinical Laboratory Service Share (%), by Country
  • Figure 8. Asia Pacific Clinical Laboratory Service Share (%), by Country
  • Figure 9. Europe Clinical Laboratory Service Share (%), by Country
  • Figure 10. MEA Clinical Laboratory Service Share (%), by Country
  • Figure 11. North America Clinical Laboratory Service Share (%), by Country
  • Figure 12. Global Clinical Laboratory Service share by Players 2022 (%)
  • Figure 13. Global Clinical Laboratory Service share by Players (Top 3) 2022(%)
  • Figure 14. Global Clinical Laboratory Service share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott (Alere) (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott (Alere) (United States) Revenue: by Geography 2022
  • Figure 18. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Siemens Healthineers (Germany) Revenue: by Geography 2022
  • Figure 20. Bio-Reference Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Bio-Reference Laboratories Inc. (United States) Revenue: by Geography 2022
  • Figure 22. Davita Labs (United States) Revenue, Net Income and Gross profit
  • Figure 23. Davita Labs (United States) Revenue: by Geography 2022
  • Figure 24. Genomic Health, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 25. Genomic Health, Inc (United States) Revenue: by Geography 2022
  • Figure 26. SYN Lab International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 27. SYN Lab International GmbH (Germany) Revenue: by Geography 2022
  • Figure 28. Enzo Biochem Inc (United States) Revenue, Net Income and Gross profit
  • Figure 29. Enzo Biochem Inc (United States) Revenue: by Geography 2022
  • Figure 30. Quest Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 31. Quest Diagnostics (United States) Revenue: by Geography 2022
  • Figure 32. Myriad Genetics (United States) Revenue, Net Income and Gross profit
  • Figure 33. Myriad Genetics (United States) Revenue: by Geography 2022
  • Figure 34. Spectra Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 35. Spectra Laboratories (United States) Revenue: by Geography 2022
  • Figure 36. NeoGenomics Laboratories Inc (United States) Revenue, Net Income and Gross profit
  • Figure 37. NeoGenomics Laboratories Inc (United States) Revenue: by Geography 2022
  • Figure 38. Labcorp (United States) Revenue, Net Income and Gross profit
  • Figure 39. Labcorp (United States) Revenue: by Geography 2022
  • Figure 40. Global Clinical Laboratory Service: by Application USD Billion (2023-2028)
  • Figure 41. Global Clinical Laboratory Service: by Tests USD Billion (2023-2028)
  • Figure 42. Global Clinical Laboratory Service: by End User USD Billion (2023-2028)
  • Figure 43. South America Clinical Laboratory Service Share (%), by Country
  • Figure 44. Asia Pacific Clinical Laboratory Service Share (%), by Country
  • Figure 45. Europe Clinical Laboratory Service Share (%), by Country
  • Figure 46. MEA Clinical Laboratory Service Share (%), by Country
  • Figure 47. North America Clinical Laboratory Service Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott (Alere) (United States)
  • Siemens Healthineers (Germany)
  • Bio-Reference Laboratories Inc. (United States)
  • Davita Labs (United States)
  • Genomic Health, Inc (United States)
  • SYN Lab International GmbH (Germany)
  • Enzo Biochem Inc (United States)
  • Quest Diagnostics (United States)
  • Myriad Genetics (United States)
  • Spectra Laboratories (United States)
  • NeoGenomics Laboratories Inc (United States)
  • Labcorp (United States)
Additional players considered in the study are as follows:
Miraca Group (Japan) , Sonic Healthcare (Australia) , Arup Laboratories (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 229 Pages 86 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott (Alere) (United States), Siemens Healthineers (Germany), Bio-Reference Laboratories Inc. (United States), Davita Labs (United States), Genomic Health, Inc (United States), SYN Lab International GmbH (Germany), Enzo Biochem Inc (United States), Quest Diagnostics (United States), Myriad Genetics (United States), Spectra Laboratories (United States), NeoGenomics Laboratories Inc (United States) and Labcorp (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Adoption of Automation Technology Like Robots in Clinical Laboratory Service " is seen as one of major influencing trends for Clinical Laboratory Service Market during projected period 2022-2028.
The Clinical Laboratory Service market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Clinical Laboratory Service Market Report?